Traws Pharma Inc (TRAW) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.62
• Market Cap: $19.42M
• EPS: $-1.82
• 52-Week High: $3.45
• 52-Week Low: $0.97

Market Sentiment

Traws Pharma Inc currently has a Neutral sentiment score of -0.07.

About Traws Pharma Inc

Traws Pharma, Inc. is a clinical-stage biopharmaceutical company headquartered in Newtown, Pennsylvania, focused on developing innovative oncology therapies. The company boasts a promising pipeline of novel treatments aimed at addressing significant unmet medical needs in cancer care. By leveraging advanced research and development capabilities, Traws Pharma is well-positioned to enhance patient outcomes and capitalize on emerging opportunities within the dynamic biopharmaceutical market, mak...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Traws Pharma Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does TRAW pay dividends?

Traws Pharma Inc (TRAW) does not currently pay a regular dividend.

What is TRAW's market cap?

Traws Pharma Inc (TRAW) has a market capitalization of $19.42M with a current stock price of $1.62.